SOLACI present at the 15 Symposium of Interventional Cardiology CardioInterv 2015

SOLACI express their gratitude to the Costantino Costantini Foundation, in Curitiba, Brazil, and to their director Dr. Costantino Costantini, for their invitation to take part in the 15 Symposium of Interventional Cardiology, CardioInterv 2015, held in Curitiba on November 26 thru 27, 2015.

The event, which took place at the Cardiology Center Costantini, proudly presented reputed international and Latin American guests and a program of outstanding scientific level. The activities included several live cases, round tables, case discussions and lectures from prestigious guests, such as doctors Andrés Íñiguez and José María de La Torre Hernández (Spain), Giulio Guagliumi and Imad Sheiban (Italy) and Jonathan M. Tobis (United States), among others.

Just like the previous year, our Society displayed a stand in the exhibition hall of the event.

More articles by this author

CHIP LATAM | Chapter 2 – Mexico: Complications Workshop

The Latin American Society of Interventional Cardiology invites the entire medical community to participate in a virtual workshop on complications organized by SOLACI’s Complex...

Fellow’s Corner 2026 – Submit Your Clinical Case

Share your experience. Learn from experts. Grow as an interventional cardiologist. The Latin American Society of Interventional Cardiology (SOLACI) is relaunching this year the Fellow’s...

Watch Again: Cardiovascular Risk Factors in Women | SOLACI Technicians Webinar

The webinar “Cardiovascular Risk Factors in Women,” held on January 27, 2026, via the Zoom platform, is now available for viewing on SOLACI’s YouTube...

Technical Training in Hemodynamics and Interventional Cardioangiology | SOLACI–CACI

The SOLACI–CACI Technical Training in Hemodynamics and Interventional Cardioangiology is an academic program designed for the initial training and professional development of non-physician healthcare...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Low-Dose Rivaroxaban After Peripheral Angioplasty: Effectiveness and Safety in Real-World Clinical Practice

Following lower limb revascularization, optimal medical therapy includes antiplatelet agents, high-intensity statins, and control of cardiovascular risk factors. Recent studies such as COMPASS and...

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...